✦ LIBER ✦

The Growth and Age-Related Origins of Bone Fragility in Men

✍ Scribed by E. Seeman

Publisher: Springer
Year: 2004
Tongue: English
Weight: 326 KB
Volume: 75
Category: Article
ISSN: 1432-0827
DOI: 10.1007/s00223-004-0289-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical assessment of bone turnover

Biochemical assessment of bone turnover and bone fragility in men

✍ P. Szulc; J. M. Kaufman; P. D. Delmas 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

Age-related decline in bone density amon

✍ Y. Sheu; J. A. Cauley; V. W. Wheeler; A. L. Patrick; C. H. Bunker; K. E. Ensrud; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 137 KB

Bone Microarchitecture and Bone Fragilit

Bone Microarchitecture and Bone Fragility in Men: DXA and Histomorphometry in Humans and in the Orchidectomized Rat Model

✍ M. Audran; D. Chappard; E. Legrand; H. Libouban; M.F. Baslé 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 283 KB

Role of parathyroid hormone in mediating

Role of parathyroid hormone in mediating age-related changes in bone resorption in men

✍ Kurt A. Kennel; B. Lawrence Riggs; Sara J. Achenbach; Ann L. Oberg; Sundeep Khos 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

Relation of age, gender, and bone mass t

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

✍ Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenb 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 278 KB 👁 2 views

Relation of age, gender, and bone mass t

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

✍ Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenb 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 278 KB 👁 2 views

Sclerostin is a potent inhibitor of Wnt signaling and bone formation. However, there is currently no information on the relation of circulating sclerostin levels to age, gender, or bone mass in humans. Thus we measured serum sclerostin levels in a population-based sample of 362 women [123 premenopau